Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
35.61
-0.02 (-0.06%)
At close: Jan 30, 2026, 4:00 PM EST
35.57
-0.04 (-0.11%)
After-hours: Jan 30, 2026, 4:15 PM EST
HRTS Holdings Information
HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 9.90%, Roche Holding AG at 5.32%, Johnson & Johnson at 4.51%, AstraZeneca at 4.34%, and Thermo Fisher Scientific at 4.19%.
Total Holdings
45
Top 10 Percentage
46.29%
Asset Class
Equity
ETF Category
Health
Assets
56.59M
PE Ratio
23.54
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 9.90% |
| 2 | RHHBY | Roche Holding AG | 5.32% |
| 3 | JNJ | Johnson & Johnson | 4.51% |
| 4 | LON: AZN | AstraZeneca PLC | 4.34% |
| 5 | TMO | Thermo Fisher Scientific Inc. | 4.19% |
| 6 | MRK | Merck & Co., Inc. | 4.02% |
| 7 | UNH | UnitedHealth Group Incorporated | 3.89% |
| 8 | CPH: NOVO.B | Novo Nordisk A/S | 3.44% |
| 9 | GILD | Gilead Sciences, Inc. | 3.44% |
| 10 | SWX: NOVN | Novartis AG | 3.23% |
| 11 | ABT | Abbott Laboratories | 3.12% |
| 12 | BSX | Boston Scientific Corporation | 3.01% |
| 13 | MDT | Medtronic plc | 2.98% |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | 2.86% |
| 15 | ABBV | AbbVie Inc. | 2.85% |
| 16 | DHR | Danaher Corporation | 2.79% |
| 17 | BBIO | BridgeBio Pharma, Inc. | 2.33% |
| 18 | AMGN | Amgen Inc. | 2.12% |
| 19 | REGN | Regeneron Pharmaceuticals, Inc. | 1.96% |
| 20 | RVMD | Revolution Medicines, Inc. | 1.92% |
| 21 | BMY | Bristol-Myers Squibb Company | 1.91% |
| 22 | MCK | McKesson Corporation | 1.82% |
| 23 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.69% |
| 24 | TEVA | Teva Pharmaceutical Industries Limited | 1.60% |
| 25 | CYTK | Cytokinetics, Incorporated | 1.58% |
As of Jan 29, 2026